补肾壮骨中药对去卵巢大鼠骨组织及血清白细胞介素-6水平的影响

被引:5
作者
黎慧清
陈璐璐
曾天舒
夏文芳
周敏
机构
[1] 华中科技大学同济医学院附属协和医院内分泌科,华中科技大学同济医学院附属协和医院内分泌科,华中科技大学同济医学院附属协和医院内分泌科,华中科技大学同济医学院附属协和医院内分泌科,华中科技大学同济医学院附属协和医院内分泌科武汉,武汉,武汉,武汉,武汉
关键词
补肾壮骨中药; 骨组织培养; 白细胞介素-6;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
1008 ;
摘要
目的 :观察补肾壮骨中药对去卵巢大鼠骨组织及血清白细胞介素 6 (IL 6 )水平的影响 ,探讨其防治骨质疏松的可能机制。方法 :将实验动物随机分成正常对照 (N)组、去卵巢对照 (OVX)组、雌激素治疗(OVX +E2 )组、中药治疗 (OVX +CM )组。各组分别在处理 2、4、6周后留取心脏血 ,并取骨组织培养 4 8h ,用ELISA方法检测骨组织培养液及血清中IL 6含量。结果 :与正常对照组比较 ,OVX组骨组织中IL 6水平随去卵巢时间延长而升高 ,6周时达高峰 ,为 2周时的 2 2 7倍。去卵巢后补充雌激素可降低骨组织中IL 6水平 ,其降低程度在 2周、4周、6周时分别为 5 0 %、70 %、80 % (P <0 0 5 )。补肾壮骨中药亦使IL 6产生减少 ,但效果不及雌激素明显 ;与OVX组比较 ,其降低水平分别为 8%、2 0 %、30 % (P <0 0 5 )。各组血清中IL 6水平随时间延长无明显变化 ,各组间比较 ,差异也无显著性 (P >0 0 5 )。结论 :补肾壮骨中药对骨组织局部IL 6产生有较强抑制作用 ,但对血清IL 6水平无明显影响。
引用
收藏
页码:116 / 119
页数:4
相关论文
共 10 条
[1]  
Elevated plasma levels of interleukin-6 in post-menopausal women do not correlate with bone density. Kania DM,Binkley N,Checovich M,et al. Journal of the American Geriatrics Society . 1995
[2]  
Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. Scheidt-Nave C,Bismar H,Leidig-Bruckner G,et al. The Journal of Clinical Endocrinology . 2001
[3]  
Evidence for an autocrine/paracrine role for interlerkin-6 in bone resorption by giant cells from giant cell tumors of bone. Ohsaki Y,Takahashi S,Scarcez J,et al. The Journal of Endocrinology . 1992
[4]  
Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Sites CK,Toth MJ,Cushman M,et al. Fertility and Sterility . 2002
[5]  
Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. Pacifici R. Journal of Bone and Mineral Research . 1996
[6]  
Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women. McKane WR,Khosla S,Peterson JM,et al. Journal of Bone and Mineral Research . 1994
[7]  
Bone marrow, cytokines, and bone remodeling.Emerging insights into the pathophysiology of osteoporosis. Manolagas SC,Jilka RL. The New England Journal of Medicine . 1995
[8]  
Bone[P]. BIRL JOSEPH J.中国专利:US2436283A,1948-02-17
[9]  
Parathyroid hormone(PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Lowik CW,Vander Pluijm G,Bloys H. Biochemical and Biophysical Research Communications . 1989
[10]  
IL-6 stimulates osteoclast-like multinucleated cell formation in long- term human marrow cultures by inducing IL-6 release. Kurihara N,Bertolini D,Suda T,et al. J Immunol . 1990